| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.48T | 3.21T | 3.39T | 3.20T | 2.51T |
| Gross Profit | 664.90B | 617.09B | 680.23B | 595.19B | 458.19B |
| EBITDA | 351.20B | 359.47B | 429.49B | 383.54B | 309.08B |
| Net Income | 134.88B | 134.36B | 176.44B | 151.74B | 126.19B |
Balance Sheet | |||||
| Total Assets | 3.66T | 3.30T | 3.26T | 3.10T | 2.90T |
| Cash, Cash Equivalents and Short-Term Investments | 376.25B | 358.71B | 367.31B | 383.59B | 356.02B |
| Total Debt | 857.40B | 758.84B | 622.66B | 513.14B | 530.48B |
| Total Liabilities | 2.00T | 1.77T | 1.73T | 1.59T | 1.51T |
| Stockholders Equity | 1.48T | 1.37T | 1.38T | 1.31T | 1.19T |
Cash Flow | |||||
| Free Cash Flow | 83.92B | 95.24B | 164.28B | 119.77B | 71.73B |
| Operating Cash Flow | 263.00B | 254.06B | 308.74B | 227.09B | 172.06B |
| Investing Cash Flow | -191.91B | -202.34B | -143.43B | -72.37B | -420.87B |
| Financing Cash Flow | -76.91B | -90.60B | -161.11B | -148.53B | 186.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.43T | 8.24 | 13.26% | 1.85% | 8.03% | 5.58% | |
66 Neutral | ¥38.34T | 10.71 | 12.89% | 2.78% | 5.51% | -18.10% | |
63 Neutral | ¥1.51T | 11.50 | ― | 3.74% | ― | ― | |
63 Neutral | ¥138.16B | 18.63 | ― | 1.29% | 15.20% | 127.27% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
45 Neutral | ¥1.24T | -2.18 | -16.69% | ― | -4.95% | 20.69% |